Symrise AG stock (DE000SYM9999): DZ Bank maintains Buy rating

DZ Bank analyst reaffirms Buy rating on Symrise AG with €92 target, as shares trade near €74 amid US market exposure.

Symrise AG (DE000SYM9999), a leading provider of flavors and fragrances, received a maintained Buy rating from DZ Bank analyst Thomas Maul on May 12, 2026. The reaffirmation comes as the stock closed at €74.02, with an average analyst target of €92.06, according to ad-hoc-news.de as of May 12, 2026. This update highlights ongoing confidence in the company's global operations, including strong US demand in food and nutrition.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Symrise AG
• Sector/industry: Specialty Chemicals
• Headquarters/country: Holzminden, Germany
• Core markets: Global, with strong US food and consumer exposure
• Key revenue drivers: Nutritional ingredients (62%), Taste, Nutrition & Health (38%)
• Home exchange/listing venue: Frankfurt (SY1.DE)
• Trading currency: EUR

Symrise AG: core business model

Symrise AG develops, produces and markets scents, flavors and functional ingredients worldwide. Founded in 1874 and based in Holzminden, Germany, the company serves industries including food, beverages, personal care, pet food and cosmetics, according to company data. Its portfolio spans nutritional ingredients for food products like beverages, dairy and animal feed, alongside perfumes and flavors.

Net sales break down into nutritional ingredients (61.8%) and perfumes/flavors (38.2%), as reported in recent financials. Symrise operates globally with significant US exposure through facilities like the new Northwest Arkansas Food Studio, enhancing customer collaboration in North America, per Symrise.com as of recent announcement.

Main revenue and product drivers for Symrise AG

Symrise AG's key revenue comes from nutritional ingredients (62%) and taste, nutrition & health segments (38%). The company innovates with products like Mindera® Euca, a plant-based protection for rinse-off cosmetics, expanding its Care & Wellness portfolio, according to Symrise.com announcement. These drivers support growth in food, pet nutrition and personal care amid rising demand for natural ingredients.

US investors note Symrise's role in the American consumer goods supply chain, with studios and partnerships boosting North American innovation. The stock's beta of 0.97 over one year indicates moderate market sensitivity, per Finbox data.

Why Symrise AG matters for US investors

Symrise AG holds relevance for US investors due to its exposure to the world's largest consumer market. With strong ties in food, beverages and personal care—key US sectors—the company's innovations like the Arkansas studio directly support American brands. Shares listed on Frankfurt (SY1.DE) offer European specialty chemicals access with USD-linked demand.

Symrise AG: Industry trends and competitive position

In the flavors and fragrances sector, Symrise AG competes with giants like Givaudan and IFF, focusing on sustainable, plant-based solutions amid ESG trends. Its global footprint and R&D investments position it well for premium ingredient demand, particularly in health-conscious US markets.

Conclusion

Symrise AG continues to demonstrate resilience in specialty chemicals, bolstered by DZ Bank's maintained Buy rating and innovations like the US Food Studio. Trading around €74 on Frankfurt, the stock reflects analyst optimism with a €92 target amid global and US-driven demand. Investors track earnings and product launches for sustained momentum in flavors and nutrition.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.